Published in J Clin Invest on January 18, 2011
The otherness of self: microchimerism in health and disease. Trends Immunol (2012) 1.46
Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat Rev Immunol (2013) 1.39
Pancreatic mesenchyme regulates epithelial organogenesis throughout development. PLoS Biol (2011) 1.27
Immunological implications of pregnancy-induced microchimerism. Nat Rev Immunol (2017) 0.91
Fetal intervention increases maternal T cell awareness of the foreign conceptus and can lead to immune-mediated fetal demise. J Immunol (2014) 0.90
In utero depletion of fetal hematopoietic stem cells improves engraftment after neonatal transplantation in mice. Blood (2014) 0.90
Fetal production of growth factors and inflammatory mediators predicts pulmonary hypertension in congenital diaphragmatic hernia. Pediatr Res (2013) 0.86
Direct and indirect antigen presentation lead to deletion of donor-specific T cells after in utero hematopoietic cell transplantation in mice. Blood (2013) 0.86
Pregnancy-associated progenitor cells: an under-recognized potential source of stem cells in maternal lung. Placenta (2011) 0.86
Alterations in maternal-fetal cellular trafficking after fetal surgery. J Pediatr Surg (2012) 0.85
Can maternal microchimeric cells influence the fetal response toward self antigens? Chimerism (2011) 0.84
Maternal-fetal cellular trafficking: clinical implications and consequences. Curr Opin Pediatr (2014) 0.84
Temporal definition of haematopoietic stem cell niches in a large animal model of in utero stem cell transplantation. Br J Haematol (2014) 0.80
In utero therapy for congenital disorders using amniotic fluid stem cells. Front Pharmacol (2014) 0.79
The maternal immune response inhibits the success of in utero hematopoietic cell transplantation. Chimerism (2011) 0.78
In utero hematopoietic cell transplantation for hemoglobinopathies. Front Pharmacol (2015) 0.78
Transplantation tolerance induced in humans at the fetal or the neonatal stage. J Transplant (2011) 0.78
Placental Hofbauer cells assemble and sequester HIV-1 in tetraspanin-positive compartments that are accessible to broadly neutralizing antibodies. J Int AIDS Soc (2015) 0.78
NK cell tolerance as the final endorsement of prenatal tolerance after in utero hematopoietic cellular transplantation. Front Pharmacol (2015) 0.77
Treatment of Hemophilia A in Utero and Postnatally using Sheep as a Model for Cell and Gene Delivery. J Genet Syndr Gene Ther (2012) 0.77
Engineering muscle tissue for the fetus: getting ready for a strong life. Front Pharmacol (2015) 0.77
Maternal microchimerism in patients with biliary atresia: Implications for allograft tolerance. Chimerism (2012) 0.76
In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application. Mol Ther Methods Clin Dev (2016) 0.76
Increased maternal T cell microchimerism in the allogeneic fetus during LPS-induced preterm labor in mice. Chimerism (2015) 0.76
Hemophilia A: an ideal disease to correct in utero. Front Pharmacol (2014) 0.75
Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model. Cytotherapy (2014) 0.75
Advancing the detection of maternal haematopoietic microchimeric cells in fetal immune organs in mice by flow cytometry. Chimerism (2014) 0.75
In utero transplantation: Disparate ramifications. World J Stem Cells (2013) 0.75
Partial rescue of mucopolysaccharidosis type VII mice with a lifelong engraftment of allogeneic stem cells in utero. Congenit Anom (Kyoto) (2015) 0.75
Boosting Hematopoietic Engraftment after in Utero Transplantation through Vascular Niche Manipulation. Stem Cell Reports (2016) 0.75
In utero hematopoietic cell transplantation: induction of donor specific immune tolerance and postnatal transplants. Front Pharmacol (2014) 0.75
Increased maternal microchimerism after open fetal surgery. Chimerism (2012) 0.75
Immunological considerations in in utero hematopoetic stem cell transplantation (IUHCT). Front Pharmacol (2015) 0.75
First steps to define murine amniotic fluid stem cell microenvironment. Sci Rep (2016) 0.75
Monitoring of Venus transgenic cell migration during pregnancy in non-transgenic rabbits. Transgenic Res (2016) 0.75
RAG-1-deficient mice have no mature B and T lymphocytes. Cell (1992) 20.97
Actively acquired tolerance of foreign cells. Nature (1953) 19.82
IMMUNOGENETIC CONSEQUENCES OF VASCULAR ANASTOMOSES BETWEEN BOVINE TWINS. Science (1945) 12.87
Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature (1992) 7.66
Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science (2008) 5.76
Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A (1996) 4.70
Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med (2000) 3.94
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med (1998) 3.86
Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int Immunol (1993) 3.67
Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol (2001) 2.93
Microchimerism of maternal origin persists into adult life. J Clin Invest (1999) 2.35
In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers. Blood (1999) 1.99
Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA (2004) 1.95
Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med (1996) 1.86
Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras. Blood (2008) 1.73
Two independent pathways of maternal cell transmission to offspring: through placenta during pregnancy and by breast-feeding after birth. Immunology (2000) 1.49
Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via In utero or postnatal transfer. Blood (1998) 1.41
In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet (1996) 1.35
Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. J Clin Invest (1994) 1.29
In utero bone marrow transplantation induces donor-specific tolerance by a combination of clonal deletion and clonal anergy. J Pediatr Surg (1999) 1.19
Evidence for an immune barrier after in utero hematopoietic-cell transplantation. Blood (2006) 1.18
Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation (1996) 1.18
Maternal plasma fetal DNA as a marker for preterm labour. Lancet (1998) 1.16
Maternal alloantibodies induce a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation in mice. J Clin Invest (2009) 1.16
Maternal cells are widely distributed in murine fetuses in utero. Biol Reprod (1996) 1.15
Bi-directional cell trafficking between mother and fetus in mouse placenta. Placenta (2006) 1.13
Influence of maternal-fetal histocompatibility and MHC zygosity on maternal microchimerism. J Immunol (2005) 1.10
Microchimerism and tolerance after in utero bone marrow transplantation in mice. J Surg Res (1998) 1.10
High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol (2005) 1.07
Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells (2008) 1.07
Fetal cell microchimerism: helpful or harmful to the parous woman? Curr Opin Obstet Gynecol (2003) 1.03
Chimerism of murine fetal bone marrow by maternal cells occurs in late gestation and persists into adulthood. Lab Invest (2003) 1.01
In utero hematopoietic stem cell transplantation: progress toward clinical application. Biol Blood Marrow Transplant (2008) 1.00
Tolerance induction or sensitization in mice exposed to noninherited maternal antigens (NIMA). Am J Transplant (2008) 0.99
The correlation of prolonged survival of maternal skin grafts with the presence of naturally transferred maternal T cells. Transplantation (1993) 0.95
The human-sheep chimeras as a model for human stem cell mobilization and evaluation of hematopoietic grafts' potential. Exp Hematol (2007) 0.94
The effect of noninherited maternal antigens in allogeneic transplantation. Semin Hematol (2005) 0.92
Mixed chimerism following in utero hematopoietic stem cell transplantation in murine models of hemoglobinopathy. Exp Hematol (2003) 0.89
In utero bone marrow transplantation induces kidney allograft tolerance across a full major histocompatibility complex barrier in Swine. Transplantation (2005) 0.87
Persistent elevation of cell-free fetal DNA levels in maternal plasma after selective laser coagulation of chorionic plate anastomoses in severe midgestational twin-twin transfusion syndrome. Am J Obstet Gynecol (2005) 0.83
Immunobiology of exposure to non-inherited maternal antigens. Front Biosci (2007) 0.81
Effect of natural killer cell depletion on long-term multilineage allogeneic bone marrow engraftment. Transplant Proc (1993) 0.81
Donor major histocompatibility complex class I expression determines the outcome of prenatal transplantation. J Pediatr Surg (2008) 0.79
Immunological tolerance following stem cell transplantation in human fetuses in utero. Transplant Proc (1997) 0.77
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat Immunol (2009) 5.20
Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature (2007) 4.94
Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol (2005) 3.28
IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab (2012) 2.80
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J Exp Med (2006) 2.68
Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules. Am J Physiol Heart Circ Physiol (2005) 2.34
Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells. Endocrinology (2007) 2.33
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J Exp Med (2010) 2.21
How do CD4+CD25+ regulatory T cells control autoimmunity? Curr Opin Immunol (2005) 2.12
Memory regulatory T cells reside in human skin. J Clin Invest (2014) 1.95
Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102. Cancer Res (2007) 1.83
Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol (2006) 1.75
Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J Immunol (2005) 1.73
Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc Natl Acad Sci U S A (2004) 1.69
Notch 1 signaling regulates peripheral T cell activation. Immunity (2004) 1.61
Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potential. Semin Immunol (2006) 1.55
T regulatory cells in autoimmune diabetes: past challenges, future prospects. J Clin Immunol (2008) 1.52
Age-related changes in vascular endothelial growth factor dependency and angiopoietin-1-induced plasticity of adult blood vessels. Circ Res (2004) 1.45
Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells. J Immunol (2011) 1.25
Amplification of autoimmune response through induction of dendritic cell maturation in inflamed tissues. J Immunol (2009) 1.18
Spontaneous development of a pancreatic exocrine disease in CD28-deficient NOD mice. J Immunol (2008) 1.14
Mechanisms of PDL1-mediated regulation of autoimmune diabetes. Clin Immunol (2007) 1.11
Prevention of diabetes by FTY720-mediated stabilization of peri-islet tertiary lymphoid organs. Diabetes (2010) 1.10
Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells. J Immunol (2006) 1.10
Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation. Am J Pathol (2011) 1.08
CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment. Nat Immunol (2003) 1.06
B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice. Proc Natl Acad Sci U S A (2011) 1.01
The role of CD28 and CTLA4 in the function and homeostasis of CD4+CD25+ regulatory T cells. Novartis Found Symp (2003) 1.00
Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice. J Gene Med (2003) 0.95
Differential glucocorticoid effects on stress-induced gene expression in the paraventricular nucleus of the hypothalamus and ACTH secretion in the rat. Stress (2009) 0.93
Plasmacytoid DCs and T(reg) cells: casual acquaintance or monogamous relationship? Nat Immunol (2006) 0.91
Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts. J Surg Res (2011) 0.91
Fetal intervention increases maternal T cell awareness of the foreign conceptus and can lead to immune-mediated fetal demise. J Immunol (2014) 0.90
In utero hematopoietic cell transplantation for the treatment of congenital anomalies. Clin Perinatol (2012) 0.90
A mouse model of in utero transplantation. J Vis Exp (2011) 0.88
Fetal production of growth factors and inflammatory mediators predicts pulmonary hypertension in congenital diaphragmatic hernia. Pediatr Res (2013) 0.86
Direct and indirect antigen presentation lead to deletion of donor-specific T cells after in utero hematopoietic cell transplantation in mice. Blood (2013) 0.86
Alterations in maternal-fetal cellular trafficking after fetal surgery. J Pediatr Surg (2012) 0.85
Donor-Reactive Regulatory T Cell Frequency Increases During Acute Cellular Rejection of Lung Allografts. Transplantation (2016) 0.80
The diagnosis and management of intradiaphragmatic extralobar pulmonary sequestrations: a report of 4 cases. J Pediatr Surg (2012) 0.79
Long-term outcomes after fetal therapy for congenital high airway obstructive syndrome. J Pediatr Surg (2012) 0.78
The maternal immune response inhibits the success of in utero hematopoietic cell transplantation. Chimerism (2011) 0.78
Maternal microchimerism in patients with biliary atresia: Implications for allograft tolerance. Chimerism (2012) 0.76
Mass Effect Alone May Not Explain Pulmonary Vascular Pathology in Severe Congenital Diaphragmatic Hernia. Fetal Diagn Ther (2015) 0.75
Caring for patients with cancer through nursing knowledge of IV connectors. Clin J Oncol Nurs (2009) 0.75
Increased maternal microchimerism after open fetal surgery. Chimerism (2012) 0.75
Assessment of Immune Isolation of Allogeneic Mouse Pancreatic Progenitor Cells by a Macroencapsulation Device. Transplantation (2016) 0.75
Type IV intestinal atresia, congenital bilateral perisylvian syndrome, and chronic pulmonary hypertension secondary to multiple vascular disruption syndrome in a monochorionic twin. J Pediatr Surg (2012) 0.75
Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy. ACS Nano (2017) 0.75
Clinical implications of maternal-fetal cellular trafficking. Semin Pediatr Surg (2013) 0.75